论文部分内容阅读
目的评价盐酸氨溴索联合盐酸丙卡特罗治疗小儿肺炎的应用价值。方法选择2016年1月~2017年2月我院收治的肺炎患儿98例为研究对象,随机分为观察组与对照组(n=49)。对照组给予盐酸氨溴索治疗,观察组给予盐酸氨溴索联合盐酸丙卡特罗治疗,对比分析两组患儿临床体征消失时间、住院时间及不良反应发生率。结果观察组临床体征消失时间、住院时间及不良反应发生率明显低于对照组,P<0.05。结论给予肺炎患儿盐酸氨溴索联合盐酸丙卡特罗治疗,治疗效果显著,既可减少患儿临床体征消失时间、住院时间,又可降低不良反应发生率,安全性较高,值得临床推广应用。
Objective To evaluate the value of ambroxol hydrochloride combined with procaterol hydrochloride in the treatment of children pneumonia. Methods From January 2016 to February 2017, 98 children with pneumonia admitted to our hospital were randomly divided into observation group and control group (n = 49). The control group was treated with ambroxol hydrochloride. The observation group was treated with Ambroxol Hydrochloride and Procaterol Hydrochloride. The clinical signs of disappearance, hospital stay and incidence of adverse reactions were compared between the two groups. Results The disappearance of clinical signs, hospitalization time and the incidence of adverse reactions in the observation group were significantly lower than those in the control group (P <0.05). Conclusion Ambroxol hydrochloride combined with procaterol hydrochloride in children with pneumonia has significant curative effect, which can not only reduce the disappearance of clinical signs and hospitalization time, but also reduce the incidence of adverse reactions, which is safe and worthy of clinical application .